Haemonetics Corp (NYSE:HAE)
| 75.89 Delayed Data As of 4:00pm ET |  +1.86 / +2.51%Today’s Change | 43.50 Today|||52-Week Range 79.45 | +43.08% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Basil Michelle L General Counsel & Executive Vice President |  Sale | 9/15/2022 | 27,769 | $77.76 | $2.2M | -2.29% |
Basil Michelle L General Counsel & Executive Vice President | Sale | 9/19/2022 | 11,448 | $78.36 | $897.1K | -3.04% |
Basil Michelle L General Counsel & Executive Vice President |  Buy | 9/15/2022 | 14,231 | $41.64 | $592.6K | -2.29% |
Kroll Mark W Director | Sale | 8/15/2022 | 8,016 | $73.71 | $590.9K | -0.03% |
Basil Michelle L General Counsel & Executive Vice President | Sale | 9/15/2022 | 6,029 | $78.50 | $473.3K | -2.29% |
Basil Michelle L General Counsel & Executive Vice President | Buy | 9/15/2022 | 11,154 | $38.43 | $428.6K | -2.29% |
Basil Michelle L General Counsel & Executive Vice President | Sale | 5/19/2022 | 3,258 | $59.10 | $192.5K | +26.08% |
Basil Michelle L General Counsel & Executive Vice President | Buy | 9/15/2022 | 3,173 | $56.57 | $179.5K | -2.29% |
Basil Michelle L General Counsel & Executive Vice President | Buy | 9/19/2022 | 4,213 | $41.64 | $175.4K | -3.04% |
Simon Christopher A President & Chief Executive Officer | Sale | 5/19/2022 | 2,496 | $59.10 | $147.5K | +26.08% |
Page of 6